A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)

Inclusion Criteria

• •Patient is male or female and at least 18 years of age.
• •Female patient must be of either:
• •* Non-childbearing potential, post-menopausal, or there is a confirmed clinical history of sterility (e.g., the patient is without a uterus)
• •* Childbearing potential, provided there are negative urine pregnancy test results prior to study treatment, to rule out pregnancy